RisuMed successfully concluded its attendance at the 2026 WHX Miami Exhibition (June 17-19). As a top-tier industry trade show, this event serves as a critical market gateway for brands accessing the North and Latin American medical device industry.
Recently, four equipment exterior designs from Risu Med Technology (Shaanxi) Co., Ltd. successfully passed review by the China National Intellectual Property Administration (CNIPA) and were officially granted design patent authorizations.
RisuMed cordially invites our industry colleagues to join us at the 2026 WHX MIAMI (World Health Expo, formerly known as FIME) in Miami, USA.
SEOUL, South Korea, March 19, 2026 -- The 40th Korea International Medical & Hospital Equipment Show (KIMES 2026) concluded with resounding success at the COEX Exhibition Centre in Seoul.
RisuMed officially achieved the National High-Tech Enterprise certification recently. This milestone signifies national authoritative recognition of the company’s technological innovation and achievement transformation, successfully positioning RisuMed among the high-tech enterprises receiving key state support.
This article focuses on the 1470nm laser, reviewing authoritative literature to answer a core question: Why does 1470nm remain the "cornerstone" of global vascular surgery guidelines today, despite the continuous emergence of new wavelengths?
In the treatment of lateral epicondylitis (tennis elbow), the core value of 980/810nm dual-wavelength high-intensity laser technology lies in its ability to achieve more comprehensive and efficient targeted repair of the disease's root cause through precise "wavelength synergy" and "comprehensive treatment targeting different tissue depths" mechanisms, thereby delivering superior clinical outcomes.
March 20th to 23rd, the 40th Korea International Medical & Hospital Equipment Show (KIMES) 2025 was held at the COEX Convention Center in Gangnam-gu, Seoul, South Korea.
We sincerely invite professional medical and aesthetic institutions worldwide to join us in defining new heights of precision medicine and quality service, based on authoritative certifications and driven by innovative technology.
To its formal establishment, the company had already completed the construction of a complete industry chain covering upstream core materials and midstream key components.